期刊文献+

Quantification of pancreatic exocrine function of chronic pancreatitis with secretin-enhanced MRCP 被引量:11

Quantification of pancreatic exocrine function of chronic pancreatitis with secretin-enhanced MRCP
下载PDF
导出
摘要 AIM:To obtain reference values for pancreatic flow output rate(PFR)and peak time(PT)in healthy volunteers and chronic pancreatitis(CP);to correlate quantification of secretin enhanced magnetic resonance cholangiopancreatography(SMRCP)of pancreatic fluid output following secretin with fecal elastase-1(FE-1)tests.METHODS:The present study includes 53 subjects comprised of 17 healthy individuals and 36 patients with CP from April 2011 to January 2013.The 36 patients with CP were divided into three groups of mild CP(n=14),moderate CP(n=19)and advanced CP(n=3)by M-ANNHEIM classification for CP..Fifty-three cases underwent FE-1 test and magnetic resonance imaging using 3.0 T-device(Signa EXCITE,GE Healthcare).Coronal T2-weighted single-shot turbo spin-echo,spiratory triggered,covering the papillae,duodenum and small bowel.MRCP was performed with a heavily T2-weighted fat-suppressed long TE HASTE sequence (thick slab 2D MRCP sequence),repeated every 2 min up to 11 min after 0.1 mL/kg secretin injection(Secrelux,Sanochemia,Germany).FE-1 test used sandwich enzyme-linked immunosorbent assay(ELISA)test(ScheBo.Tech,Germany).RESULTS:A good linear correlation showed between the calculated volume and the actual volume by Phantom experiments.Fifty-three paired Quantification of secretin enhanced magnetic resonance cholangiopancreatography(MRCPQ)and FE-1 data sets were analyzed.The mean FE-1 of 53 cases was 525.41±94.44μg/g for 17 healthy volunteers,464.95±136.13μg/g for mild CP,301.55±181.55μg/g for moderate CP,229.30±146.60μg/g for advanced CP.Also,there was statistically significant difference in FE-1(P=0.0001)between health and CP.The mean values of PFR and PT were 8.18±1.11 mL/min,5.76±1.71 min for normal;7.27±2.04 mL/min,7.71±2.55 min for mild CP;4.98±2.57 mL/min,9.10±3.00 min for moderate CP;4.13±1.83 mL/min,12.33±1.55 min for advanced CP.Further,statistically significant difference in PFR(P=0.0001)and PT(P=0.0001)was observed between health and CP.Besides,there was correlation(r=0.79)and consistency(K=0.6)between MRCPQ and ELISA Test.It was related between M-ANNHEIM classification and PFR(r=0.55),FE-1(r=0.57).CONCLUSION:SMRCP can provide a safe,non-invasive and efficient method to evaluate the exocrine function of the pancreas. AIM: To obtain reference values for pancreatic flow output rate (PFR) and peak time (PT) in healthy volunteers and chronic pancreatitis (CP); to correlate quantification of secretin enhanced magnetic resonance cholangiopancreatography (SMRCP) of pancreatic fluid output following secretin with fecal elastase-1 (FE-1) tests. METHODS: The present study includes 53 subjects comprised of 17 healthy individuals and 36 patients with CP from April 2011 to January 2013. The 36 patients with CP were divided into three groups of mild CP (n = 14), moderate CP (n = 19) and advanced CP (n = 3) by M-ANNHEIM classification for CP.. Fifty-three cases underwent FE-1 test and magnetic resonance imaging using 3.0 T-device (Signa EXCITE, GE Healthcare). Coronal T2-weighted single-shot turbo spin-echo, spiratory triggered, covering the papillae, duodenum and small bowel. MRCP was performed with a heavily T2-weighted fat-suppressed long TE HASTE sequence (thick slab 2D MRCP sequence), repeated every 2 min up to 11 min after 0.1 mL/kg secretin injection (Secrelux, Sanochemia?, Germany). FE-1 test used sandwich enzyme-linked immunosorbent assay (ELISA) test (ScheBo. Tech?, Germany). RESULTS: A good linear correlation showed between the calculated volume and the actual volume by Phantom experiments. Fifty-three paired Quantification of secretin enhanced magnetic resonance cholangiopancreatography (MRCPQ) and FE-1 data sets were analyzed. The mean FE-1 of 53 cases was 525.41 ± 94.44 μg/g for 17 healthy volunteers, 464.95 ± 136.13 μg/g for mild CP, 301.55 ± 181.55 μg/g for moderate CP, 229.30 ± 146.60 μg/g for advanced CP. Also, there was statistically significant difference in FE-1 (P = 0.0001) between health and CP. The mean values of PFR and PT were 8.18 ± 1.11 mL/min, 5.76 ± 1.71 min for normal; 7.27 ± 2.04 mL/min, 7.71 ± 2.55 min for mild CP; 4.98 ± 2.57 mL/min, 9.10 ± 3.00 min for moderate CP; 4.13 ± 1.83 mL/min, 12.33 ± 1.55 min for advanced CP. Further, statistically significant difference in PFR (P = 0.0001) and PT (P = 0.0001) was observed between health and CP. Besides, there was correlation (r = 0.79) and consistency (K = 0.6) between MRCPQ and ELISA Test. It was related between M-ANNHEIM classification and PFR (r = 0.55), FE-1 (r = 0.57). CONCLUSION: SMRCP can provide a safe, non-invasive and efficient method to evaluate the exocrine function of the pancreas.
出处 《World Journal of Gastroenterology》 SCIE CAS 2013年第41期7177-7182,共6页 世界胃肠病学杂志(英文版)
关键词 SECRETIN MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY Pancreatic EXOCRINE function Chronic PANCREATITIS MAGNETIC RESONANCE imaging Secretin Magnetic resonance cholangiopancreatography Pancreatic exocrine function Chronic pancreatitis Magnetic resonance imaging
  • 相关文献

参考文献33

  • 1Tyler Stevens,Mansour A Parsi.Update on endoscopic pancreatic function testing[J].World Journal of Gastroenterology,2011,17(35):3957-3961. 被引量:5
  • 2R. Manfredi,S. Perandini,W. Mantovani,L. Frulloni,N. Faccioli,R. Pozzi Mucelli.Quantitative MRCP assessment of pancreatic exocrine reserve and its correlation with faecal elastase-1 in patients with chronic pancreatitis[J]. La radiologia medica . 2012 (2)
  • 3Prateek D. Wali,Beth Loveridge-Lenza,Zhaoping He,Karoly Horvath.Comparison of Fecal Elastase-1 and Pancreatic Function Testing in Children[J]. Journal of Pediatric Gastroenterology and Nutrition . 2012 (2)
  • 4Temel Tirkes,Christine O. Menias,Kumaresan Sandrasegaran.MR Imaging Techniques for Pancreas[J]. Radiologic Clinics of North America . 2012 (3)
  • 5Katrin Hoffmann,Christiane Kerner,Wolfgang Wilfert,Marc Mueller,Joachim Thiery,Johann Hauss,Helmut Witzigmann.Detection of disseminated pancreatic cells by amplification of cytokeratin-19 with quantitative RT-PCR in blood,bone marrow and peritoneal lavage of pancreatic carcinoma patients[J].World Journal of Gastroenterology,2007,13(2):257-263. 被引量:21
  • 6Alexander Schneider,J. Matthias L?hr,Manfred V. Singer.The M-ANNHEIM classification of chronic pancreatitis: introduction of a unifying classification system based on a review of previous classifications of the disease[J]. Journal of Gastroenterology . 2007 (2)
  • 7Arne R. J. Schneider,Renate Hammerstingl,Matthias Heller,Nada Povse,Lydia Murzynski,Thomas J. Vogl,Wolfgang F. Caspary,Juergen Stein.Does Secretin-stimulated MRCP Predict Exocrine Pancreatic Insufficiency?: A Comparison With Noninvasive Exocrine Pancreatic Function Tests[J]. Journal of Clinical Gastroenterology . 2006 (9)
  • 8Syed A. Ahmad,Curtis J. Wray,Horacio R. Rilo,Kyuran A. Choe,Andres Gelrud,John Howington,Andrew M. Lowry,Jeffrey B. Matthews.Chronic Pancreatitis: Recent Advances and Ongoing Challenges[J]. Current Problems in Surgery . 2006 (3)
  • 9M. A. Bali,A. Sztantics,T. Metens,M. Arvanitakis,M. Delhaye,J. Devière,C. Matos.Quantification of pancreatic exocrine function with secretin-enhanced magnetic resonance cholangiopancreatography: normal values and short-term effects of pancreatic duct drainage procedures in chronic pancreatitis. Initial results[J]. European Radiology . 2005 (10)
  • 10E Siegmund,J L?hr,P Schuff-Werner.Die diagnostische Validit?t nichtinvasiver Pankreasfunktionstests - Eine Metaanalyse[J]. Z Gastroenterol . 2004 (10)

二级参考文献66

  • 1[1]Jemal A,Murray T,Samuels A,Ghafoor A,Ward E,Thun MJ.Cancer statistics 2003.CA Cancer J Clin 2003; 53:5-26
  • 2[2]Parkin DM,Bray FI,Devesa SS.Cancer burden in the year 2000.The global picture.Eur J Cancer 2001; 37 Suppl 8:S4-S66
  • 3[3]Neoptolemos JP,Stocken DD,Friess H,Bassi C,Dunn JA,Hickey H,Beger H,Fernandez-Cruz L,Dervenis C,Lacaine F,Falconi M,Pederzoli P,Pap A,Spooner D,Kerr DJ,Buchler MW.A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.N Engl J Med 2004; 350:1200-1210
  • 4[4]Wagner M,Redaelli C,Lietz M,Seiler CA,Friess H,Buchler MW.Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma.Br J Surg 2004; 91:586-594
  • 5[5]Griffin JF,Smalley SR,Jewell W,Paradelo JC,Reymond RD,Hassanein RE,Evans RG.Patterns of failure after curative resection of pancreatic carcinoma.Cancer 1990; 66:56-61
  • 6[6]Westerdahl J,Andren-Sandberg A,Ihse I.Recurrence of exocrine pancreatic cancer-local or hepatic? Hepatogastroenterology 1993; 40:384-387
  • 7[7]Vogel I,Kalthoff H,Henne-Bruns D,Kremer B.Detection and prognostic impact of disseminated tumor cells in pancreatic carcinoma.Pancreatology 2002; 2:79-88
  • 8[8]Bilchik A,Miyashiro M,Kelley M,Kuo C,Fujiwara Y,Nakamori S,Monden M,Hoon DS.Molecular detection of metastatic pancreatic carcinoma cells using a multimarker reverse transcriptase-polymerase chain reaction assay.Cancer 2000; 88:1037-1044
  • 9[9]Leach SD,Rose JA,Lowy AM,Lee JE,Charnsangavej C,Abbruzzese JL,Katz RL,Evans DB.Significance of peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreatic head.Surgery 1995; 118:472-478
  • 10[10]Meszoely IM,Lee JS,Watson JC,Meyers M,Wang H,Hoffman JP.Peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreas.Am Surg 2004; 70:208-213; discussion 213-214

共引文献24

同被引文献74

引证文献11

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部